Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females

Journal of Lipid Research

Volumn 40, Issue 7, 1999, Pages 1211-1221

  De Elizabeth R, Oliveira E Silva ^a   Kong, Margaret ^a   Han, Zhihua ^a   Starr, Catherine ^a   Kass, Elizabeth M ^a   Juo, Suh Hang Hank ^a,b   Foster, David ^c   Dansky, Hayes M ^a   Merkel, Martin ^a   Cundey, Katherine ^a   Brinton, Eliot A ^a,d   Breslow, Jan L ^a   Smith, Jonathan D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c University of Washington   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

ApoA I; ApoA II; Genetics; HDL turnover; Lipoproteins; Metabolism

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; ENZYME ACTIVITY; FEMALE; GENE CLUSTER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MENOPAUSE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; BODY MASS INDEX; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; LIPASE; LIPOPROTEINS, HDL; LIVER; MIDDLE AGED; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; TRIGLYCERIDES;

EID: 0345643332     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Castelli, W. P., R. J. Garrison, P. W. Wilson, R. D. Abbott, S. Kalousdian, and W. B. Kannel. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. J. Am. Med. Assoc. 256: 2835-2838.
2. Gordon, D. J., J. L. Probstfield, R. J. Garrison, J. D. Neaton, W. P. Castelli, J. D. Knoke, D. J. Jacobs, S. Bangdiwala, and H. A. Tyroler. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79: 8-15.
3. Heller, D. A., F. U. de, N. L. Pedersen, G. Dahlen, and G. E. McClearn. 1993. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med. 328: 1150-1156.
4. Steinmetz, J., E. Boerwinkle, R. Gueguen, S. Visvikis, J. Henny, and G. Siest. 1992. Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis. 92: 219-227.
5. Perusse, L., T. Rice, J. P. Despres, J. Bergeron, M. A. Province, J. Gagnon, A. S. Leon, D. C. Rao, J. S. Skinner, J. H. Wilmore, and C. Bouchard. 1997. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler. Thromb. Vasc. Biol. 17: 3263-3269.
6. Schaefer, E. J., L. A. Zech, L. L. Jenkins, T. J. Bronzert, E. A. Rubalcaba, F. T. Lindgren, R. L. Aamodt, and H. B. Brewer, Jr. 1982. Human apolipoprotein A-I and A-II metabolism. J. Lipid Res. 23: 850-862.
7. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1989. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J. Clin. Invest. 84: 262-269.
8. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1990. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J. Clin. Invest. 85: 144-151.
9. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1991. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87: 536-544.
10. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1994. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler. Thromb. 14: 707-720.
11. Horowitz, B. S., I. J. Goldberg, J. Merab, T. M. Vanni, R. Ramakrishnan, and H. N. Ginsberg. 1993. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J. Clin. Invest. 91: 1743-1752.
12. Fidge, N., P. Nestel, T. Ishikawa, M. Reardon, and T. Billington. 1980. Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. Metabolism. 29: 643-653.
13. Le, N. A., and H. N. Ginsberg. 1988. Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. Metabolism. 37: 614-617.
14. Gylling, H., G. L. Vega, and S. M. Grundy. 1992. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J. Lipid Res. 33: 1527-1539.
15. De Oliveira e Silva, E. R., D. Foster, M. M. Harper, and E. A. Brinton. 1996. Alcohol raises HDL by increasing production of apo A-I and apo A-II. Circulation Suppl. 94: I-265-I-266.
16. Breslow, J. L. 1995. Familial disorders of high-density lipoprotein metabolism. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 2031-2052.
17. Cohen, J. C., Z. Wang, S. M. Grundy, M. R. Stoesz, and R. Guerra. 1994. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94: 2377-2384.
18. Guerra, R., J. Wang, S. M. Grundy, and J. C. Cohen. 1997. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94: 4532-4537.
19. Jansen, H., A. J. Verhoeven, L. Weeks, J. J. Kastelein, D. J. Halley, D. A. van, J. W. Jukema, J. C. Seidell, and J. C. Birkenhager. 1997. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler. Thromb. Vasc. Biol. 17: 2837-2842.
20. Tahvanainen, E., M. Syvanne, M. H. Frick, S. Murtomaki-Repo, M. Antikainen, Y. A. Kesaniemi, H. Kauma, A. Pasternak, M. R. Taskinen, and C. Ehnholm. 1998. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOGAT Study Investigators. J. Clin. Invest. 101: 956-960.
21. Murtomaki, S., E. Tahvanainen, M. Antikainen, L. Tiret, V. Nicaud, H. Jansen, and C. Ehnholm. 1997. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler. Thromb. Vasc. Biol. 17: 1879-1884.
22. Vega, G. L., L. T. Clark, A. Tang, S. Marcovina, S. M. Grundy, and J. C. Cohen. 1998. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J. Lipid Res. 39: 228-232.
23. Smith, J. D., E. A. Brinton, and J. L. Breslow. 1992. Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J. Clin. Invest. 89: 1796-1800.
24. Lipid Research Clinics Program: The Prevalence Study. 1980. U.S. Department of Health and Human Services, National Institutes of Health.
25. Harris, J. A., and F. G. Benedict. 1919. A Biometric Study of Basal Metabolism in Man. JB Lippincott, Philadelphia.
26. Mahalko, J. R., and L. K. Johnson. 1980. Accuracy of predictions of long-term energy needs. J. Am. Diet. Assoc. 77: 557-561.
27. 131I-labelled plasma proteins. Phys. Med. Biol. 2: 36-53.
28. Barrett, P. H., B. M. Bell, C. Cobelli, H. Golde, A. Schumitzky, P. Vicini, and D. M. Foster. 1998. SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism. 47: 484-492.
29. Denke, M. A., and J. L. Breslow. 1988. Effects of a low fat diet with and without intermittent saturated fat and cholesterol ingestion on plasma lipid, lipoprotein, and apolipoprotein levels in normal volunteers. J. Lipid Res. 29: 963-969.
30. Otvos, J. D., E. J. Jeyarajah, D. W. Bennett, and R. M. Krauss. 1992. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38: 1632-1638.
31. Otvos, J. D. 1997. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. In Handbook of Lipoprotein Testing. N. Rifai, G. R. Warnick, and M. H. Dominiczak, editors. AACC, Washington, DC. 497-508.
32. Emi, M., L. L. Wu, M. A. Robertson, R. L. Myers, R. A. Hegele, R. R. Williams, R. White, and J. M. Lalouel. 1988. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics. 3: 373-379.
33. Kamboh, M. I., C. E. Aston, C. M. Nestlerode, A. E. McAllister, and R. F. Hamman. 1996. Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol. Atherosclerosis. 127: 255-262.
34. Shoulders, C. C., T. M. Narcisi, A. Jarmuz, D. J. Brett, J. D. Bayliss, and J. Scott. 1993. Characterization of genetic markers in the 5′ flanking region of the apo A1 gene. Hum. Genet. 91: 197-198.
35. Dammerman, M., L. A. Sandkuijl, J. L. Halaas, W. Chung, and J. L. Breslow. 1993. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc. Natl. Acad. Sci. USA. 90: 4562-4566.
36. Hixson, J. E., and P. K. Powers. 1991. Restriction isotyping of human apolipoprotein A-IV: rapid typing of known isoforms and detection of a new isoform that deletes a conserved repeat. J. Lipid Res. 32: 1529-1535.
37. Clay, M. A., H. H. Newnham, and P. J. Barter. 1991. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler. Thromb. 11: 415-422.
38. Koizumi, J., A. Inazu, K. Yagi, I. Koizumi, Y. Uno, K. Kajinami, S. Miyamoto, P. Moulin, A. R. Tall, H. Mabuchi, and R. Takeda. 1991. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis. 90: 189-196.